HC Wainwright Maintains Buy on Praxis Precision Medicine, Sets $1201 PT
HC Wainwright & Co. reiterated a Buy rating on Praxis Precision Medicine with a price target of $1201.00, representing a 323.5% upside from its previous close.
HC Wainwright & Co. reiterated a Buy rating on Praxis Precision Medicine with a price target of $1201.00, representing a 323.5% upside from its previous close.